111 related articles for article (PubMed ID: 2421926)
41. Monoclonal anti-idiotypic antibody vaccines against poliovirus, canine parvovirus, and rabies virus.
Rimmelzwaan GF; Bunschoten EJ; UytdeHaag FG; Osterhaus AD
Methods Enzymol; 1989; 178():375-90. PubMed ID: 2481213
[No Abstract] [Full Text] [Related]
42. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
Humphrey DD; Kew OM; Feorino PM
Infect Immun; 1982 May; 36(2):841-3. PubMed ID: 6282759
[TBL] [Abstract][Full Text] [Related]
43. [Use of monoclonal antibodies for the intratypic differentiation of strains of poliomyelitis type I virus].
Lashkevich VA; Mustafina AN; Koroleva GA; Gracheva LA; Grishina KG
Vopr Virusol; 1987; 32(2):183-8. PubMed ID: 2440185
[TBL] [Abstract][Full Text] [Related]
44. Hybridoma antibodies to poliovirus N and H antigen.
Brioen P; Sijens RJ; Vrijsen R; Rombaut B; Thomas AA; Jackers A; Boeyé A
Arch Virol; 1982; 74(4):325-30. PubMed ID: 6187316
[No Abstract] [Full Text] [Related]
45. Development of allogenic hybridomas for production of monoclonal antibodies against oral polio vaccine strains.
Gupta CK; Sokhey J; Gupta RK; Singh H
Vaccine; 1991 Nov; 9(11):853-4. PubMed ID: 1661979
[No Abstract] [Full Text] [Related]
46. A human-human hybridoma which produces antibodies to polioviruses.
Chu CT; Yang SY; Yang CS
Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):284-8. PubMed ID: 2561573
[TBL] [Abstract][Full Text] [Related]
47. Epitope evolution in poliovirus maturation.
Rombaut B; Vrijsen R; Boeyé A
Arch Virol; 1983; 76(4):289-98. PubMed ID: 6194772
[TBL] [Abstract][Full Text] [Related]
48. Poliovirus antigenic sites and vaccines.
Wimmer E; Jameson BA; Emini EA
Nature; 1984 Mar 1-7; 308(5954):19. PubMed ID: 6199673
[No Abstract] [Full Text] [Related]
49. Persistence and class-specificity of neutralizing antibody response induced by trypsin-cleaved type 3 poliovirus in mice.
Roivainen M; Piirainen L; Hovi T
Vaccine; 1993; 11(7):713-7. PubMed ID: 7688171
[TBL] [Abstract][Full Text] [Related]
50. Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF).
Meager A; Parti S; Leung H; Peil E; Mahon B
Hybridoma; 1987 Jun; 6(3):305-11. PubMed ID: 2439440
[TBL] [Abstract][Full Text] [Related]
51. Demonstration of antigenic differences between strains of poliovirus type 1 by agar diffusion precipitation reaction.
Savinskaya SS; Shekoyan LA; Shirman GA
Acta Virol; 1979 May; 23(3):183-8. PubMed ID: 92184
[TBL] [Abstract][Full Text] [Related]
52. A monoclonal antibody to prednisone: use of enzyme-linked immunosorbent assay (ELISA) for screening and characterization of antigenic determinants.
Lewis JG; Elder PA; Yeo KH
J Steroid Biochem; 1986 Nov; 25(5A):659-63. PubMed ID: 2432355
[TBL] [Abstract][Full Text] [Related]
53. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
Payment P; Trudel M; Thibodeau L; Lecomte J
Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
[TBL] [Abstract][Full Text] [Related]
54. A WHO Collaborative study on assays of the antigenic content of inactivated poliovirus vaccines.
Wood DJ; Heath AB; Sawyer LA
Biologicals; 1995 Mar; 23(1):83-94. PubMed ID: 7619442
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of poliovirus with beta-propiolactone.
Jiang SD; Pye D; Cox JC
J Biol Stand; 1986 Apr; 14(2):103-9. PubMed ID: 3020055
[TBL] [Abstract][Full Text] [Related]
56. A convenient enzyme-linked immunosorbent assay for testing whether monoclonal antibodies recognize the same antigenic site. Application to hybridomas specific for the beta 2-subunit of Escherichia coli tryptophan synthase.
Friguet B; Djavadi-Ohaniance L; Pages J; Bussard A; Goldberg M
J Immunol Methods; 1983 Jun; 60(3):351-8. PubMed ID: 6189914
[TBL] [Abstract][Full Text] [Related]
57. An ELISA to detect monoclonal antibodies specific for lipid determinants of Mycoplasma pneumoniae.
Morrison-Plummer J; Jones DH; Baseman JB
J Immunol Methods; 1983 Nov; 64(1-2):165-78. PubMed ID: 6196412
[TBL] [Abstract][Full Text] [Related]
58. [Use of monoclonal antibodies in virology].
Lashkevich VA
Vopr Virusol; 1983; 28(6):648-54. PubMed ID: 6322450
[No Abstract] [Full Text] [Related]
59. Neutralizing site of poliovirus.
Brown F
Nature; 1983 Aug 4-10; 304(5925):395-6. PubMed ID: 6192343
[No Abstract] [Full Text] [Related]
60. Improvement of methods for intratypic differentiation of polioviruses. I. Agar gel diffusion precipitation test with repeated addition of antigens for differentiation between wild and vaccine polioviruses type 1 and 2.
Chumakov MP; Rubin SG; Balayan MS; Savinskaya SS; Voroshilova MK; Zhevandrova VI; Shekoyan LA; Kazantseva VA
Arch Gesamte Virusforsch; 1974; 46(1-2):61-5. PubMed ID: 4374167
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
